Nurix Therapeutics Shares Plunge on Sanofi's Termination of Drug Development ProgramGlobal News Select Nov 3, 2026, 10:11:00 PM
Roche Licenses Nurix Therapeutics Blood-Cancer Drug for Up to $2.3 Billion — UpdateGlobal News Select Jun 8, 2026, 3:44:00 PM
Roche Enters $2.3 Billion Blood-Cancer Drug Deal With Nurix TherapeuticsGlobal News Select Jun 8, 2026, 5:42:00 AM